Related Experiment Video
Updated: Apr 7, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
A population-based study on blood lead levels in blood donors
Gilles Delage1, Suzanne Gingras2, Marc Rhainds2,3
1Héma-Québec, Saint-Laurent, Québec.
Insights
Blood lead levels (BLLs) in donors were assessed, with 15.5% exceeding the 0.15 µmol/L threshold. Age and sex were primary predictors of BLLs, crucial for neonatal transfusion safety.
Area of Science:
- Environmental Health
- Toxicology
- Public Health
Background:
- Emerging evidence suggests blood transfusions may be a significant source of lead exposure in premature infants.
- This study aimed to assess blood lead levels (BLLs) in a representative blood donor population.
- It also sought to identify risk factors associated with elevated BLLs (≥0.15 µmol/L).
Purpose of the Study:
- Determine BLLs in Quebec blood donors.
- Identify risk factors for elevated BLLs.
- Inform transfusion practices for neonates.
Main Methods:
- A cross-sectional study conducted in Quebec from 2006-2007.
- Included 3490 eligible blood donors providing demographic and lifestyle information via questionnaire.
- Blood lead analysis performed using inductively coupled plasma mass spectrometry.
Main Results:
- The geometric mean BLL was 0.082 µmol/L (95% CI, 0.027-0.247).
- 15.5% of participants had BLLs exceeding 0.15 µmol/L.
- Multivariate analysis revealed age and sex as primary determinants of BLLs, alongside region, education, dwelling age, occupational/leisure activities, smoking, and alcohol intake.
Conclusions:
- Blood lead levels in donors are significantly influenced by age and sex.
- These demographic factors should be considered when evaluating transfusion risks for neonates.
- Findings highlight the importance of understanding donor BLLs for transfusion safety.
Background:
Recent studies suggested that blood transfusion may represent a significant source of lead exposure in premature infants. Objectives of this study were to determine blood lead levels (BLLs) in a representative sample of blood donors and to identify risk factors associated with BLLs of 0.15 µmol/L or more.
Study Design And Methods:
A study was conducted in 2006 to 2007 in 49 drive sites in Quebec. Individuals who qualified for blood donation were eligible to participate. Information was harvested from blood donor file and a standardized self-administered questionnaire. Lead analysis was performed by inductively coupled plasma mass spectrometry. Data on Quebec blood donors from 2003 to 2006 (n = 320,543) were used to establish a reference population. Geometric mean (GM) and 95% confidence interval (CI) were used to describe the results. The project was approved by an ethics committee.
Results:
Of 6715 eligible individuals, 3490 participated (1392 women and 2098 men). Their mean age was 46.5 years. Results were weighted for region, sex, and age. The GM of BLLs was 0.082 µmol/L (95% CI, 0.027-0.247; range, 0.011-2.90 µmol/L). BLLs of more than 0.15 µmol/L were found in 15.5% of participants. In multivariate analysis, BLLs were mainly explained by age and sex of participants (p < 0.001). A significant association was also found between BLLs and the region of residence, education level, dwelling age, occupational and leisure activities at high risk for lead exposure, smoking, and alcohol intake (p < 0.001).
Conclusion:
BLL in blood donors is strongly explained by sex and age, a fact that can be taken into consideration when transfusing neonates.
More Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bioavailability Study Design: Healthy Subjects Versus Patients